If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,396.00    -2.00 (-0.14%)
Bid:
1,392.00
Ask:
1,410.00
Spread: 18.00 (1.293%)
Market Cap: £639.79m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Share Options

14 Aug 2013 10:38

RNS Number : 6754L
Cohort PLC
14 August 2013
 



14 August 2013 AIM: CHRT

PRESS RELEASE

COHORT PLC ("Cohort")

Share Options

Option Grant

Cohort announces that on 13 August 2013 the following approved options over ordinary shares of 10 pence each were granted to Cohort directors pursuant to the Cohort plc Savings Related Share Option Scheme established on 16 February 2006 (and approved by HM Revenue & Customs on 10 April 2006) ("SAYE Scheme"):

Director

Number of shares under this option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,330

154.5

6,041

SR Walther

5,825

154.5

15,103

 

The options are made pursuant to three year savings contracts.

Option Exercise

Cohort announces that it has issued and allotted 170,164 new ordinary shares of 10p each in the capital of Cohort pursuant to the exercise of share options under the Cohort plc 2006 Share Option Scheme and the SAYE Scheme.

Following this exercise, Cohort's issued share capital consists of 40,958,616 ordinary shares of 10p each with voting rights. Cohort does not hold any shares in treasury.

Therefore, the total number of voting rights in Cohort is 40,958,616. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Cohort under the FCA's Disclosure and Transparency Rules.

Application has been made for admission of these shares to trading on AIM and dealings in the new ordinary shares are expected to commence on 19 August 2013.

 

Ends

 

For further information, please contact

 

Cohort plc

 

Andrew Thomis, Chief Executive

Simon Walther, Finance Director

+44 (0)118 909 0390

 

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins, Ben Griffiths

+44 (0)20 3128 8100

 

 

Cohort plc (www.cohortplc.com) (@Cohortplc)

 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through three market-facing subsidiary companies:

Ÿ MASS (www.mass.co.uk) - a specialist systems house with considerable experience in the defence market and a focus on information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

 

Ÿ SCS (www.scs-ltd.co.uk) - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

 

Ÿ SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space and transport market sectors. Acquired by Cohort in October 2007.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire and Somerset.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWSULFDSEDA
Date   Source Headline
13th Dec 20237:00 amRNSHalf Year Results
7th Dec 20237:00 amRNSEquity Development Presentation on 13 December
5th Dec 20237:00 amRNSContract Win
1st Dec 20239:55 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSNotice of Half Year Results
6th Nov 202310:21 amRNSHolding(s) in Company
3rd Nov 202310:35 amRNSHolding(s) in Company
1st Nov 202310:03 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSSHARES/AJ BELL IN-PERSON INVESTOR EVENT NEXT WEEK
16th Oct 20237:00 amRNSShares/AJ Bell Live Investor Event, October 25
13th Oct 20234:03 pmRNSDirector/PDMR Shareholding
6th Oct 20233:48 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:09 pmRNSBlock listing six monthly return
2nd Oct 20231:04 pmRNSTotal Voting Rights
29th Sep 202310:18 amRNSDirector/PDMR Shareholding
26th Sep 20235:00 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Statement & First Quarter Update
21st Sep 20233:45 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSTotal Voting Rights
30th Aug 20232:34 pmRNSDirector/PDMR Shareholding
24th Aug 20233:26 pmRNSBlock listing six monthly return
24th Aug 20232:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Aug 20237:00 amRNSContract Win
11th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20231:39 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTotal Voting Rights
2nd Jun 20238:02 amRNSTotal Voting Rights
30th May 20238:00 amRNSContract Win
26th May 20239:56 amRNSEBT Purchase of Shares
25th May 20237:00 amRNSFull Year Trading Update
22nd May 20233:15 pmRNSEBT Purchase of Shares
15th May 20233:27 pmRNSEBT Purchase of Shares
10th May 20235:56 pmRNSEBT Purchase of Shares
9th May 202311:41 amRNSHolding(s) in Company
9th May 20239:16 amRNSContract Win
2nd May 20232:47 pmRNSDirector/PDMR Shareholding
2nd May 20232:42 pmRNSEBT Purchase of Shares
2nd May 20232:36 pmRNSTotal Voting Rights
27th Apr 20239:00 amRNSContract Announcement
5th Apr 20237:00 amRNSContract Announcement
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSBlock Listing Six Monthly Return
23rd Mar 20237:00 amRNSMASS contracted to supply EW Operation Support
22nd Mar 20237:00 amRNSChess awarded contract extension
14th Mar 202310:30 amRNSDirector/PDMR Shareholding
1st Mar 202312:38 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNSRecording of Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.